These trials completed more than 12 months ago and should have reported results. Some have, some have not.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Ongoing 2008-001237-95 Aprepitant in the prevention of delayed emesis induced by moderately emetogenic chemotherapy (cyclophosphamide + anthracycline) in breast cancer patients: a double-blind randomized study not-yet-due
Ongoing 2008-001339-37 Aprepitant in the prevention of cisplatin-induced delayed emesis: a double-blind randomized study not-yet-due
Not reported Terminated 2022-000391-19 A Single Arm Phase II Study of CAbozantinib in relapsing IDH-1wt, MET amplified Glioblastoma: (“CAT” Study) Sperimentazione clinica di fase 2 a singolo braccio con CAbozantinib nel glioblastoma rec... 2023-10-24 due-trials